|

The Per-procedural Antibiotic Prophylaxis in Patients Undergoing Transcatheter Aortic Valve Implantation Trial

RECRUITINGN/ASponsored by Copenhagen University Hospital, Rigshospitalet
Actively Recruiting
PhaseN/A
SponsorCopenhagen University Hospital, Rigshospitalet
Started2026-10-01
Est. completion2030-03-31
Eligibility
Age18 Years+
Healthy vol.Accepted

Summary

The study is a prospective, crossover, cluster randomized trial in patients undergoing transcatheter aortic valve implantation (TAVI). The study tests whether cephalosporin plus beta-lactam antibiotic with spectrum for Enterococcus faecalis as per procedural prophylaxis is superior to cephalosporin alone in reducing the composite outcome of bacteremia or death at 6 months post-TAVI.

Eligibility

Age: 18 Years+Healthy volunteers accepted
Inclusion Criteria:

* All patients \> 18 years of age undergoing TAVI at sites in Denmark

Exclusion Criteria:

* Patients who do not want to participate and have chosen to "opt-out" of the trial

Conditions2

Aortic Valve StenosisHeart Disease

Interventions1

Browse More Trials

Trial data from ClinicalTrials.gov. Trial status and eligibility can change — verify directly with the study contact or on ClinicalTrials.gov.

This site does not provide medical advice. Always consult your doctor before considering enrollment in a clinical trial. Learn more on our About page.